Lung Cancer
Latest News
NSCLC therapies associated with cardiac events
Several targeted NSCLC therapies are strongly associated with cardiac adverse events, such as conduction disease, QT prolongation, and heart...
Latest News
EMA panel endorses two cancer drugs, one sickle cell drug
Tepotinib for NSCLC, enfortumab vedotin for urothelial cancer and voxelotor for sickle cell disease are currently approved in the U.S.
Latest News
Earlier lung cancer detection may drive lower mortality
Few eligible patients undergo CT screening despite survival benefits.
Feature
What causes cancer? There’s a lot we don’t know
Obesity status over time may be more relevant to cancer risk than one-off measures.
Opinion
Benefits of low-dose CT scanning for lung cancer screening explained
CHEST gives 18 recommendations and further evidence of the benefits of CT screening.
Latest News
Doctors as trusted messengers
Oncologists are increasingly stepping up for a new role on the front lines of battling cancer-causing air pollution. A new ProPublica report...
Rare Diseases Report 2021
Mesothelioma trials: Moving toward improved survival
Latest News
Physicians may be overprescribing immunotherapy for unfit cancer patients
Study suggests the benefits from ICI therapy may not translate to patients who are traditionally excluded from phase 3 trials.
From the Journals
Can aspirin prolong survival in patients with NSCLC?
“Any potential benefit of aspirin in lung cancer patients needs to be balanced against known adverse events associated with prolonged aspirin use...
Latest News
Three drugs go head-to-head in advanced lung cancer study
This is the first-known analysis that compares atezolizumab, nivolumab, and docetaxel in patients outside of clinical trials. Atezolizumab and...
Latest News
Common lung cancer screening tool superior to alternatives
CT scans are increasingly used for lung cancer screening, so accuracy is essential in devising an appropriate treatment plan for patients.